SMYD3 and neoplasm: Necroscopic evaluation revealed the complete absence of tumor masses in 60% of EM127-treated mice vs 0% of mice treated with the vehicle (Fig. 8b), suggesting a role for SMYD3 inhibition in preventing CRC metastatic spreading.